Mayo Clinic moves cancer care to the home: 5 notes
Discover how Mayo Clinic is transforming cancer care by providing in-home treatments and expanding the program to more patients and locations.
Related Articles
AMA Medical Student Advocacy Conference (MAC)
The 2025 American Medical Association Medical Student Advocacy Conference (MAC) will be held March 6-7, 2025. Registration is now open.
Care for Patients With a History of Immigration
This JAMA Insights explores how considering clinical factors and/or potential exposures during the premigration, migration, and postmigration phases of immigration could help clinicians more effectively…
Characteristics of Preteen Suicide in Japan
This cross-sectional study evaluates characteristics of preteen suicide rates in Japan over the past 15 years using data from national suicide statistics.
I spent hours testing ChatGPT Tasks – and its refusal to follow directions was mildly terrifying
ChatGPT tasks offers AI prompt scheduling and automation, but what happens when things go wrong? I explored the highs and lows of this promising yet…
Validation of the Walter Index for Posthospitalization Mortality Prediction
This prognostic study investigates whether the Walter Index, developed to assess 12-month mortality risk in US older adults after hospitalization, has comparable predictive accuracy among…
Motif Neurotech picks up grant to develop brain-computer interface
Motif Neurotech has received a multi-million dollar grant to support the development of a therapeutic brain-computer interface (BCI).
HIV Diagnosis, STEMI is A Failed Paradigm, Poisoned Patient Airway Management, SBP | EM Quick Hits | EM Cases
Testing patients for HIV in the ED, failed paradigm of STEMI criteria for acute coronary occlusion, when to intubate the tox patient, SBP pearls, DIY…
Differential Censoring Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials
This comparative effectiveness study examines whether differential censoring could explain the inconsistent results in trials investigating the addition of programmed cell death 1 protein/programmed cell…
Genotype-Guided P2Y12 Inhibitor Monotherapy Within 7 Days of Percutaneous Coronary Intervention in High Bleeding Risk Patients
To test the feasibility and safety of genotype guidance in the selection of P2Y12 monotherapy within 1 week of percutaneous coronary interventions (PCIs) among patients…
Medical apprenticeships: what next now that the scheme has been paused?
In December it emerged that the medical apprenticeship programme had been paused—a move that has implications for the institutions spearheading courses and for the future…
